Nasdaq
NDAQ
754 hedge funds and large institutions have $28.8B invested in Nasdaq in 2024 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 320 increasing their positions, 253 reducing their positions, and 76 closing their positions.
64% more call options, than puts
Call options by funds: $55.8M | Put options by funds: $34M
26% more repeat investments, than reductions
Existing positions increased: 320 | Existing positions reduced: 253
0% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 76
0.57% less ownership
Funds ownership: 83.48% → 82.9% (-0.57%)
5% less capital invested
Capital invested by funds: $30.3B → $28.8B (-$1.5B)
1% less funds holding
Funds holding: 763 → 754 (-9)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$259M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$207M |
| 3 |
Man Group
London,
United Kingdom
|
-$129M |
| 4 |
Holocene Advisors
New York
|
-$64.9M |
| 5 |
SC
Samlyn Capital
New York
|
-$64.2M |
NDAQ Hedge Fund Activity: Q2 2024 in Review
754 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Nasdaq (NDAQ) for Q2 2024, worth a combined $28.8B — down 4.9% from $30.3B a quarter earlier.
Fund positioning in NDAQ was balanced in Q2 2024: 76 funds opened new positions, 76 closed out, 320 added to existing stakes and 253 trimmed.
The largest buyer was Harris Associates, opening a new position worth an estimated $454M. The largest seller was Millennium Management, cutting an estimated $259M.
- 754 institutional investors held Nasdaq (NDAQ) as of Q2 2024, down from 763 in Q1 2024.
- Funds reported $28.8B of Nasdaq stock for Q2 2024, down 4.9% quarter-over-quarter.
- 76 funds opened new Nasdaq positions in Q2 2024 and 76 closed out, a net change of 0 holders.
- The largest Nasdaq buyer in Q2 2024 was Harris Associates, an estimated $454M added.
- The largest Nasdaq seller in Q2 2024 was Millennium Management, an estimated $259M sold.
Based on aggregated 13F filings for Q2 2024.